Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mitochondrial remodeling underlying age-induced skeletal muscle wasting: let's talk about sex.
Moreira-Pais A, Vitorino R, Sousa-Mendes C, Neuparth MJ, Nuccio A, Luparello C, Attanzio A, Novák P, Loginov D, Nogueira-Ferreira R, Leite-Moreira A, Oliveira PA, Ferreira R, Duarte JA. Moreira-Pais A, et al. Among authors: nuccio a. Free Radic Biol Med. 2024 Jun;218:68-81. doi: 10.1016/j.freeradbiomed.2024.04.005. Epub 2024 Apr 2. Free Radic Biol Med. 2024. PMID: 38574975 Free article.
Blinded independent central review versus local investigator assessment of PFS in RCTs of immunotherapy in advanced cancers: A systematic review and meta-analysis.
D'Ambrosio S, Salomone F, Vitale F, Avanzo A, Viggiano A, Liguori L, Ferrara R, Nuccio A, Viscardi G, Napolitano F, Santaniello A, Formisano L, Bianco R, Servetto A. D'Ambrosio S, et al. Among authors: nuccio a. Eur J Cancer. 2024 Oct 20;213:115077. doi: 10.1016/j.ejca.2024.115077. Online ahead of print. Eur J Cancer. 2024. PMID: 39454538 Free article.
Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis.
Marinelli D, Nuccio A, Di Federico A, Ambrosi F, Bertoglio P, Faccioli E, Ferrara R, Ferro A, Giusti R, Guerrera F, Mammana M, Pittaro A, Sepulcri M, Viscardi G, Gallina FT. Marinelli D, et al. Among authors: nuccio a. J Thorac Oncol. 2024 Oct 8:S1556-0864(24)02374-8. doi: 10.1016/j.jtho.2024.09.1443. Online ahead of print. J Thorac Oncol. 2024. PMID: 39389220
Stereologic consequences of iatrogenic collapse: The morphology of adenocarcinoma in situ overlaps with invasive patterns. Proposal for a necessary modified classification of pulmonary adenocarcinomas.
Filipello F, Blaauwgeers H, Lissenberg-Witte B, Schonau A, Doglioni C, Arrigoni G, Radonic T, Bahce I, Smit A, Dickhoff C, Nuccio A, Bulotta A, Minami Y, Noguchi M, Ambrosi F, Thunnissen E. Filipello F, et al. Among authors: nuccio a. Lung Cancer. 2024 Oct 5;197:107987. doi: 10.1016/j.lungcan.2024.107987. Online ahead of print. Lung Cancer. 2024. PMID: 39388963 Free article.
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC.
Hines JB, Cameron RB, Esposito A, Kim L, Porcu L, Nuccio A, Viscardi G, Ferrara R, Veronesi G, Forde PM, Taube J, Vokes E, Bestvina CM, Dolezal JM, Sacco M, Monteforte M, Cascone T, Garassino MC, Torri V. Hines JB, et al. Among authors: nuccio a. J Thorac Oncol. 2024 Jul;19(7):1108-1116. doi: 10.1016/j.jtho.2024.03.010. Epub 2024 Mar 8. J Thorac Oncol. 2024. PMID: 38461929 Free article.
Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies.
Nuccio A, Viscardi G, Salomone F, Servetto A, Venanzi FM, Riva ST, Oresti S, Ogliari FR, Viganò M, Bulotta A, Cameron R, Esposito A, Hines J, Bianco R, Reni M, Cascone T, Garassino MC, Torri V, Veronesi G, Cinquini M, Ferrara R. Nuccio A, et al. Eur J Cancer. 2023 Dec;195:113404. doi: 10.1016/j.ejca.2023.113404. Epub 2023 Oct 26. Eur J Cancer. 2023. PMID: 37948842
Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle?
Venanzi FM, Bini M, Nuccio A, De Toma A, Lambertini M, Ogliari FR, Oresti S, Viganò MG, Brioschi E, Polignano M, Naldini MM, Riva S, Ferrara M, Fogale N, Damiano G, Russo V, Reni M, Veronesi G, Foggetti G, Conforti F, Bulotta A, Ferrara R. Venanzi FM, et al. Among authors: nuccio a. Cancer Treat Rev. 2023 Dec;121:102648. doi: 10.1016/j.ctrv.2023.102648. Epub 2023 Oct 26. Cancer Treat Rev. 2023. PMID: 37918169 Review.
Dynamic ADP-Ribosylome, Phosphoproteome, and Interactome in LPS-Activated Macrophages.
Daniels CM, Kaplan PR, Bishof I, Bradfield C, Tucholski T, Nuccio AG, Manes NP, Katz S, Fraser IDC, Nita-Lazar A. Daniels CM, et al. Among authors: nuccio ag. J Proteome Res. 2020 Sep 4;19(9):3716-3731. doi: 10.1021/acs.jproteome.0c00261. Epub 2020 Jul 1. J Proteome Res. 2020. PMID: 32529831 Free PMC article.
18 results